ZSP inhibits GBM growth in vitro and reduces the stem cell markers Nestin and CD133 by downregulating the Notch2 receptor, which targets Hairy/Enhancer of Split 1 (Hes1) to induce apoptosis. The gene discussed is HES1; the disease is glioblastoma.